{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:10:37Z","timestamp":1788844237493,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Atopic Dermatitis Control Tool (ADCT) serves as a key metric for assessing atopic dermatitis (AD) management. However, the relationship between eczema severity in different body regions and inadequate control in AD patients has not been extensively researched. This study aimed to examine this association in both children and adults with AD and to further explore temporality and treatment effects through longitudinal follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional questionnaire survey was conducted on pediatric and adult patients with AD in Guangzhou, China. The questionnaires were completed by the AD patients attending the Department of Dermatology at Guangdong Provincial Hospital of Chinese Medicine between March, 2024 and December, 2025. Additionally, a longitudinal sub-cohort of 96 AD patients with 24-week follow-up data was retrospectively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 713 AD patients completed the survey, including 175 children (aged 12\u201317 years old) and 538 adults. In the pediatric group, the severity of the head and neck and lower limbs was independently associated with inadequate disease control. In the adult group, the severity of the lower limbs was independently associated with poor disease control. In the longitudinal cohort, improvements in disease severity of the head and neck and lower limbs from baseline to week 24 were independently associated with ADCT-defined clinical improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The AD control status exhibits age-specific regional associations. Longitudinal data further demonstrate that reductions in disease severity in the head and neck and lower limbs were independently associated with clinical improvement. These findings are exploratory and require prospective validation before they can inform treatment prioritization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/falgy.2026.1888094","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:26:34Z","timestamp":1788841594000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between severity of different body regions and inadequate control of atopic dermatitis: results from a cross-sectional and longitudinal study"],"prefix":"10.3389","volume":"7","author":[{"given":"Zifan","family":"Li","sequence":"first","affiliation":[{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Yu","sequence":"additional","affiliation":[{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Dermatology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)","place":["Guangzhou, China"]},{"name":"Guangdong Clinical Research Center for Chinese Medicine Dermatology","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40257-024-00853-4","article-title":"Early and sustained improvements in symptoms and quality of life with upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: 52-week results from two phase III randomized clinical trials (measure up 1 and measure\u00a0up\u00a02)","volume":"25","author":"Silverberg","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1111\/jdv.17335","article-title":"Measurement properties of patient-reported outcome measures for eczema control: a systematic review","volume":"35","author":"Stuart","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/bjd\/ljaf167","article-title":"Harmonizing measurement of eczema control: mapping scores between the atopic dermatitis control tool and the recap of atopic eczema instrument","volume":"193","author":"Gillespie","year":"2025","journal-title":"Br J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"adv00618","DOI":"10.2340\/actadv.v101.750","article-title":"The atopic dermatitis control tool: a high-performance tool for optimal support","volume":"101","author":"Staumont-Sall\u00e9","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2500\/aap.2019.40.4265","article-title":"Atopic dermatitis","volume":"40","author":"Peters","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jaad.2023.04.052","article-title":"Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: a cross sectional study from the TARGET-DERM AD cohort","volume":"89","author":"Silverberg","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.36849\/jdd.2020.5422","article-title":"Impact of atopic dermatitis lesion location on quality of life in adult patients in a real-world study","volume":"19","author":"Lio","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1111\/exd.14368","article-title":"Head and neck severity index is associated to a significant worsening of quality of life in atopic dermatitis patients","volume":"30","author":"Ribero","year":"2021","journal-title":"Exp Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/03007995.2019.1699516","article-title":"Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the atopic dermatitis control tool (ADCT)","volume":"36","author":"Pariser","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/der.0000000000000895","article-title":"The eczema area and severity Index\u2014a practical guide","volume":"33","author":"Hanifin","year":"2022","journal-title":"Dermatitis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2340\/00015555-2642","article-title":"Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment","volume":"97","author":"Reich","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1365-2133.2008.08832.x","article-title":"The dermatology life quality Index 1994\u20132007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/bjd.12590","article-title":"Translating patient-oriented eczema measure POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods","volume":"169","author":"Charman","year":"2013","journal-title":"Br J Dermatol"},{"key":"B15","year":"2025"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1111\/ijd.70260","article-title":"Minimal disease activity as A new therapeutic target in atopic dermatitis: a 5-year real-life experience with dupilumab","volume":"65","author":"Leo","year":"2026","journal-title":"Int J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/jdv.70172","article-title":"Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6\u2009years","volume":"40","author":"Bunick","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/bjd\/ljae056","article-title":"Evaluating the clinical utility of the atopic dermatitis control tool: measurement properties and agreement between patients\u2019 responses and clinicians\u2019 impressions of atopic dermatitis control","volume":"190","author":"Simpson","year":"2024","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/1346-8138.16176","article-title":"Atopic dermatitis control tool (ADCT): a useful tool for self-evaluation in patients with atopic dermatitis","volume":"48","author":"Kido-Nakahara","year":"2021","journal-title":"J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4168\/aair.2025.17.4.519","article-title":"Utility of the atopic dermatitis control tool for assessing long-term control of atopic dermatitis in Korean patients on dupilumab","volume":"17","author":"Bae","year":"2025","journal-title":"Allergy Asthma Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.15586\/aei.v53i1.1197","article-title":"Establishing the degree of control in patients with atopic dermatitis with the atopic dermatitis control tool (ADCT)","volume":"53","author":"Weinmann","year":"2025","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/antib14040104","article-title":"Head and neck dermatitis in atopic dermatitis: a narrative review of pathogenesis, clinical challenges, and therapeutic strategies","volume":"14","author":"Lauletta","year":"2025","journal-title":"Antibodies (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/jdv.18849","article-title":"A nationwide 104\u2009weeks real-world study of dupilumab in adults with atopic dermatitis: ineffectiveness in head-and-neck dermatitis","volume":"37","author":"Vittrup","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1111\/ijd.17256","article-title":"Patient and family burden in pediatric atopic dermatitis and its treatment pattern in Japan","volume":"63","author":"Otsuka","year":"2024","journal-title":"Int J Dermatol"},{"key":"B25","year":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s13555-022-00694-1","article-title":"Rapidity of improvement in signs\/symptoms of moderate-to-severe atopic dermatitis by body region with abrocitinib in the phase 3 JADE COMPARE study","volume":"12","author":"Alexis","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/1346-8138.14116","article-title":"Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis","volume":"45","author":"Wei","year":"2018","journal-title":"J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/biomedicines10112927","article-title":"Atopic dermatitis: clinical aspects and unmet needs","volume":"10","author":"Lobefaro","year":"2022","journal-title":"Biomedicines"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1888094\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:26:35Z","timestamp":1788841595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1888094\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":28,"alternative-id":["10.3389\/falgy.2026.1888094"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1888094","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1888094"}}